SC144

CAS No. 895158-95-9

SC144( —— )

Catalog No. M17647 CAS No. 895158-95-9

SC144 is an orally active small-molecule gp130 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 61 In Stock
25MG 125 In Stock
50MG 210 In Stock
100MG 353 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SC144
  • Note
    Research use only, not for human use.
  • Brief Description
    SC144 is an orally active small-molecule gp130 inhibitor.
  • Description
    SC144 is an orally active small-molecule gp130 inhibitor.
  • In Vitro
    SC144 inhibits cell growth in a panel of human ovarian cancer cell lines with IC50s in a submicromolar range (IC50=OVCAR-8, OVCAR-5, OVCAR-3= 0.72, 0.49, 0.95 μM).The potency of SC144 toward NCI/ADR-RES (Paclitaxel- and Doxorubicin-resistant, IC50=0.43 μM) and HEY (Cisplatin-resistant, IC50=0.88 μM) suggests an ability to overcome drug resistance in ovarian cancer.SC144 (2 μM; 24 hours) causes significantly more apoptosis in OVCAR-8 and Caov-3 than normal kidney epithelial and normal endometrial cells.SC144 (0.5-2 μM; 0-6 hours) substantially increases the phosphorylation of gp130 (S782) in both OVCAR-8 and Caov-3 cells in a time- and dose-dependent manner.SC144 is cytotoxic to ovarian cancer cells via a mechanism involving the inhibition of gp130 activity, leading to the inactivation of Akt and Stat3 as well as the suppression of Stat3-regulated gene expression. As are result, SC144 treatment eventually causes cell-cycle arrest, anti-angiogenesis, and apoptosis. Apoptosis Analysis Cell Line:OVCAR-8 and Caov-3 cells Concentration:2 μM Incubation Time:24 hours Result:Significantly caused cell death in OVCAR-8 and Caov-3 cells.Western Blot Analysis Cell Line:OVCAR-8, Caov-3 cells Concentration:0.5-2 μM Incubation Time:0-6 hours Result:Substantially increased the phosphorylation of gp130 (S782) in both OVCAR-8 and Caov-3 cellsin a time- and dose-dependent manner.
  • In Vivo
    SC144 (10 mg/kg; i.p.; daily for 58 days) suppresses tumor growth in human ovariancancer xenografts.SC144 (100 mg/kg;p.o.; daily for 35 days) treatment shows the average tumor volume in mice 82% smaller than that in the control group. Animal Model:Athymic mice (human ovarian cancer xenograft)Dosage:10 mg/kg Administration:I.p; daily for 58 days Result:Significantly inhibited tumor growth by about 73%.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    gp130
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    895158-95-9
  • Formula Weight
    322.3
  • Molecular Formula
    C16H11FN6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 19.5 mg/mL. 60.50 mM;
  • SMILES
    Fc1cc2c(cc1)n1cccc1c(NNC(=O)c1cnccn1)n2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Oshima T, et al. Anticancer Drugs, 2009, 20(5), 312-320.
molnova catalog
related products
  • 2-(Methylamino)-1H-p...

    2-(Methylamino)-1H-purin-6(7H)-one is an endogenous methylated nucleoside found in human fluids and a modified nucleoside.

  • Gentisin

    Gentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity.

  • BVDV-IN-1

    BVDV-IN-1 is a non-nucleoside inhibitor (NNI) of bovine viral diarrhea virus (BVDV), with an EC50 of 1.8 μM.?It directly binds to a hydrophobic pocket of the BVDV RdRp.